Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Commentary: Shoot the renals!

F C Luft1, C M Gross

  • 1Medical Faculty of the Charité, Franz-Volhard Clinic, HELIOS Klinikum Berlin-Brandenburg, Berlin, Germany. Luft@charite.de

Heart (British Cardiac Society)
|November 16, 2007
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

[Dermatological side effects during therapy with serotonin noradrenaline reuptake inhibitors].

Der Nervenarzt·2008
Same author

Preparation of protected peptidyl thioester intermediates for native chemical ligation by Nalpha-9-fluorenylmethoxycarbonyl (Fmoc) chemistry: considerations of side-chain and backbone anchoring strategies, and compatible protection for N-terminal cysteine.

The journal of peptide research : official journal of the American Peptide Society·2005
Same author

An Internet-based simulation model for nitrogen management in agricultural settings.

TheScientificWorldJournal·2003
Same author

Determination of renal arterial stenosis severity: comparison of pressure gradient and vessel diameter.

Radiology·2001
Same author

[Renovascular illness: prevalence and therapy in patients with coronary heart disease].

Zeitschrift fur Kardiologie·2000
Same author

Clinical and angiographic outcome in patients with in-stent restenosis and repeat target lesion revascularisation in small coronary arteries.

Heart (British Cardiac Society)·2000
Same journal

Feasibility of early double sequential defibrillation in out-of-hospital cardiac arrest: the double-D randomised pilot trial.

Heart (British Cardiac Society)·2026
Same journal

Correspondence on 'When a patent foramen ovale becomes pathological' by Saji and Ohara.

Heart (British Cardiac Society)·2026
Same journal

Cost-effectiveness of N-terminal pro-B-type natriuretic peptide thresholds for echocardiography referral in primary care heart failure management.

Heart (British Cardiac Society)·2026
Same journal

Optimal timing of aspirin discontinuation after acute coronary syndrome treated with percutaneous coronary intervention: a systematic review and meta-analysis.

Heart (British Cardiac Society)·2026
Same journal

Importance of rating: the impact of establishing age and sex normative values for left ventricular strain rate.

Heart (British Cardiac Society)·2026
Same journal

Man in his 40s with palpitations.

Heart (British Cardiac Society)·2026
See all related articles

Atherosclerotic renal artery stenosis (ARAS) is a growing problem causing hypertension and kidney failure. Current guidelines for revascularization in high-risk patients with ARAS may be ill-advised due to lack of proven benefit.

Area of Science:

  • Cardiology
  • Nephrology
  • Vascular Medicine

Background:

  • Atherosclerotic renal artery stenosis (ARAS) is an increasingly prevalent condition.
  • ARAS can lead to severe hypertension and end-stage renal disease.
  • Patients with ARAS often succumb to cardiovascular or cerebrovascular events rather than renal failure.

Purpose of the Study:

  • To critically evaluate the current guidelines for revascularization in patients with ARAS.
  • To question the unproven efficacy of interventions like stenting and angioplasty for ARAS.

Main Methods:

  • Review of existing literature and clinical guidelines concerning ARAS management.
  • Analysis of the implications of recent American Heart Association guidelines.

Related Experiment Videos

Main Results:

  • The benefits of revascularization (stenting/angioplasty) for ARAS remain unproven.
  • Current guidelines suggest revascularization for a broad population, potentially encompassing most patients with atherosclerosis.
  • The widespread application of these guidelines may be inappropriate given the lack of demonstrated efficacy.

Conclusions:

  • The current approach to managing ARAS, particularly the broad recommendation for revascularization, requires critical reassessment.
  • Further evidence is needed to support the routine use of interventions for ARAS.
  • Guidelines should be more judicious in recommending revascularization for atherosclerotic renal artery stenosis.